1. Clinical Overview
Clotrimazole is a broad-spectrum synthetic imidazole antifungal agent used topically. It is a first-line treatment for superficial fungal infections caused by dermatophytes, yeasts (Candida), and Malassezia species. In the 1% w/v concentration, it is primarily formulated as a topical solution, cream, lotion, or spray for cutaneous application. It acts by inhibiting ergosterol synthesis, a critical component of fungal cell membranes, leading to increased membrane permeability and cell death.
| Onset | Duration | Bioavailability |
|---|---|---|
| Symptomatic relief (e.g., itching, burning) may begin within 24-72 hours of application. Clinical improvement is typically seen within 1 week. | The antifungal effect persists for several hours post-application. Treatment duration is typically 2-4 weeks to ensure eradication and prevent relapse. | Negligible systemic absorption (<0.5%) when applied to intact skin. Absorption may be slightly higher on inflamed, broken skin or mucous membranes but remains minimal. |
2. Mechanism of Action
Clotrimazole is a fungistatic and fungicidal agent. Its primary mechanism is the inhibition of the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase. This enzyme is crucial for converting lanosterol to ergosterol, the main sterol component of fungal cell membranes.
3. Indications & Uses
- Cutaneous Candidiasis (intertrigo, paronychia)
- Dermatophytoses (Tinea corporis, Tinea cruris, Tinea pedis)
- Pityriasis Versicolor (Tinea versicolor)
4. Dosage & Administration
Adult Dosage: Apply a thin layer to the affected and surrounding skin area twice daily (morning and evening). For Pityriasis versicolor, once daily application may be sufficient.
Administration: 1. Wash and dry the affected area thoroughly. 2. Apply a sufficient amount to cover the affected area and about 1 inch of the surrounding healthy skin. 3. Gently massage until absorbed. 4. Wash hands before and after application (unless hands are the treatment site). 5. For intertriginous areas (skin folds), apply sparingly. 6. Continue use for at least 2 weeks or for at least 1 week after symptoms have cleared to prevent recurrence.
5. Side Effects
Common side effects may include:
- Localized erythema (redness)
- Mild stinging or burning sensation at application site
- Mild irritation, itching, or peeling
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Amphotericin B | Potential antagonism of antifungal effect; concurrent use is generally not recommended. | Moderate |
| Other topical corticosteroids (e.g., Betamethasone, Clobetasol) in combination products | Combination may mask signs of infection or cause skin atrophy with prolonged use. Use fixed-dose combinations (e.g., Clobetasol + Clotrimazole) only under strict medical supervision for specified durations. | Moderate |
| Tacrolimus, Pimecrolimus (topical calcineurin inhibitors) | Theoretical risk of increased local immunosuppression; sequential use should be monitored. | Low |
7. Patient Counselling
- DO wash and dry the area thoroughly before application.
- DO use the medication for the full prescribed time, even if symptoms improve early.
- DO wear loose-fitting, breathable clothing if treating areas like groin or feet.
- DON'T apply to eyes, mouth, inside the nose, or deep into the ear canal.
- DON'T use occlusive dressings (like plastic wraps) unless directed by the doctor.
- DON'T share your medication with others, even if they have similar symptoms.
8. Toxicology & Storage
Overdose: Topical overdose is unlikely to cause systemic toxicity. Symptoms would be limited to severe local skin reactions: intense redness, burning, blistering, peeling, or ulceration.
Storage: Store at room temperature (15-25°C), protected from light and moisture. Do not freeze. Keep the container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack.